Vaccines are powerful tools that can help those living in nursing homes avoid or curtail common seasonal infections, such as the flu, RSV, COVID-19 and pneumonia.

Senate committee members heard arguments on a bill that would place a 10-year pause on administering mRNA vaccines in Idaho ...

EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...

Both the Finnish and the U.S. bird flu vaccines are made by CSL Seqirus but are different vaccines. In the summer, U.S. officials stockpiled 4.8 million doses of the vaccine that officials said was ...

President Donald Trump's plan to shrink the size of the federal work force targeted CDC training and other programs for the ...

Moderna MRNA announced fourth-quarter 2024 results. Though earnings and sales beat estimates, both metrics declined ...

BofA analyst Tim Anderson lowered the firm’s price target on Moderna (MRNA) to $32 from $34 and keeps an Underperform rating on the shares.

Health care providers say that hesitation and outright resistance to vaccines have become disturbingly common even in ...

Norovirus infection rates are extremely high this year, raising the question: Why can’t a vaccine protect us from the stomach ...

A group of leading American doctors and scientists is sounding the alarm after confirming that “severe” cases of heart and brain damage are a “reaction” to Covid mRNA “vaccines.” The warning was ...